Видео ютуба по тегу Astrazeneca Cardiac Risk

Are you at risk of another heart attack?
Are you at risk of another heart attack?
How do cellular clocks influence cardiovascular health?
How do cellular clocks influence cardiovascular health?
The future of heart failure research and treatment
The future of heart failure research and treatment
Know the danger before it becomes major
Know the danger before it becomes major
Heart Failure awareness with World Heart Federation and AstraZeneca
Heart Failure awareness with World Heart Federation and AstraZeneca
Why heart failure is an important disease area
Why heart failure is an important disease area
AstraZeneca an 'unacceptable risk' for under 60's
AstraZeneca an 'unacceptable risk' for under 60's
The implications of low awareness of heart failure
The implications of low awareness of heart failure
The next chapter for Healthy Heart Africa
The next chapter for Healthy Heart Africa
Stimulating cardiac cell growth
Stimulating cardiac cell growth
Living with cardiovascular disease: a conversation with Geoff Whitington of Fixing Dad
Living with cardiovascular disease: a conversation with Geoff Whitington of Fixing Dad
COVID vaccine linked to heart problems
COVID vaccine linked to heart problems
New muscle for failing hearts
New muscle for failing hearts
Policy makers’ awareness of heart failure
Policy makers’ awareness of heart failure
HEALTHY HEART - AstraZeneca NTV UGANDA
HEALTHY HEART - AstraZeneca NTV UGANDA
Uncovering disease drivers and novel targets in heart failure
Uncovering disease drivers and novel targets in heart failure
The use of wearables in heart failure clinical trials
The use of wearables in heart failure clinical trials
Use of RAASi in Patients with Heart Failure, Dr. Bruce Spinowitz Part 3
Use of RAASi in Patients with Heart Failure, Dr. Bruce Spinowitz Part 3
Assessing and Managing Cardiovascular Risk in Patients With CLL
Assessing and Managing Cardiovascular Risk in Patients With CLL
IS BAXDROSTAT THE BREAKTHROUGH HYPERTENSION TREATMENT PATIENTS NEED?
IS BAXDROSTAT THE BREAKTHROUGH HYPERTENSION TREATMENT PATIENTS NEED?